160 related articles for article (PubMed ID: 12950960)
1. Hepatic and systemic haemodynamic changes after MARS in patients with acute on chronic liver failure.
Catalina MV; Barrio J; Anaya F; Salcedo M; Rincón D; Clemente G; Bañares R
Liver Int; 2003; 23 Suppl 3():39-43. PubMed ID: 12950960
[TBL] [Abstract][Full Text] [Related]
2. Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure.
Laleman W; Wilmer A; Evenepoel P; Elst IV; Zeegers M; Zaman Z; Verslype C; Fevery J; Nevens F
Crit Care; 2006; 10(4):R108. PubMed ID: 16859530
[TBL] [Abstract][Full Text] [Related]
3. Acute systemic, splanchnic and renal haemodynamic changes induced by molecular adsorbent recirculating system (MARS) treatment in patients with end-stage cirrhosis.
Donati G; Piscaglia F; Colì L; Silvagni E; Righini R; Donati G; Pini P; Stefoni S; Bolondi L
Aliment Pharmacol Ther; 2007 Sep; 26(5):717-26. PubMed ID: 17697205
[TBL] [Abstract][Full Text] [Related]
4. The effect of molecular adsorbent recirculating system on pathophysiological parameters in patients with acute liver failure.
Lai WK; Haydon G; Mutimer D; Murphy N
Intensive Care Med; 2005 Nov; 31(11):1544-9. PubMed ID: 16155752
[TBL] [Abstract][Full Text] [Related]
5. Albumin dialysis reduces portal pressure acutely in patients with severe alcoholic hepatitis.
Sen S; Mookerjee RP; Cheshire LM; Davies NA; Williams R; Jalan R
J Hepatol; 2005 Jul; 43(1):142-8. PubMed ID: 15878216
[TBL] [Abstract][Full Text] [Related]
6. Hepatic and systemic hemodynamic derangements predict early mortality and recovery in patients with acute-on-chronic liver failure.
Garg H; Kumar A; Garg V; Kumar M; Kumar R; Sharma BC; Sarin SK
J Gastroenterol Hepatol; 2013 Aug; 28(8):1361-7. PubMed ID: 23488990
[TBL] [Abstract][Full Text] [Related]
7. A prospective evaluation of pulmonary, systemic and hepatic haemodynamics in HIV-HCV-coinfected patients before and after antiviral therapy with pegylated interferon and ribavirin.
Reiberger T; Payer BA; Ferlitsch A; Sieghart W; Breitenecker F; Aichelburg MC; Schmied B; Rieger A; Trauner M; Peck-Radosavljevic M;
Antivir Ther; 2012; 17(7):1327-34. PubMed ID: 22948263
[TBL] [Abstract][Full Text] [Related]
8. Molecular adsorbent recirculating system (MARS).
Tan HK
Ann Acad Med Singap; 2004 May; 33(3):329-35. PubMed ID: 15175774
[TBL] [Abstract][Full Text] [Related]
9. Effects of transjugular intrahepatic portasystemic shunt (TIPS) on splanchnic and systemic hemodynamics, and hepatic function in patients with portal hypertension. Preliminary results.
Rodríguez-Laiz JM; Bañares R; Echenagusia A; Casado M; Camuñez F; Pérez-Roldán F; de Diego A; Cos E; Clemente G
Dig Dis Sci; 1995 Oct; 40(10):2121-7. PubMed ID: 7587778
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic changes during a single treatment with the molecular adsorbents recirculating system in patients with acute-on-chronic liver failure.
Schmidt LE; Sørensen VR; Svendsen LB; Hansen BA; Larsen FS
Liver Transpl; 2001 Dec; 7(12):1034-9. PubMed ID: 11753905
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic studies in acute-on-chronic liver failure.
Kumar A; Das K; Sharma P; Mehta V; Sharma BC; Sarin SK
Dig Dis Sci; 2009 Apr; 54(4):869-78. PubMed ID: 18688717
[TBL] [Abstract][Full Text] [Related]
12. Hepatic blood flow and splanchnic oxygen consumption in patients with liver failure. Effect of high-volume plasmapheresis.
Clemmesen JO; Gerbes AL; Gülberg V; Hansen BA; Larsen FS; Skak C; Tygstrup N; Ott P
Hepatology; 1999 Feb; 29(2):347-55. PubMed ID: 9918909
[TBL] [Abstract][Full Text] [Related]
13. Hyperdynamic circulation in portal-hypertensive rat model: a primary factor for maintenance of chronic portal hypertension.
Vorobioff J; Bredfeldt JE; Groszmann RJ
Am J Physiol; 1983 Jan; 244(1):G52-7. PubMed ID: 6849394
[TBL] [Abstract][Full Text] [Related]
14. Effect of treatment with the Molecular Adsorbents Recirculating System on arterial amino acid levels and cerebral amino acid metabolism in patients with hepatic encephalopathy.
Schmidt LE; Tofteng F; Strauss GI; Larsen FS
Scand J Gastroenterol; 2004 Oct; 39(10):974-80. PubMed ID: 15513337
[TBL] [Abstract][Full Text] [Related]
15. Is MARS system enough for A. phalloides-induced liver failure treatment?
Sorodoc L; Lionte C; Sorodoc V; Petris O; Jaba I
Hum Exp Toxicol; 2010 Oct; 29(10):823-32. PubMed ID: 20179021
[TBL] [Abstract][Full Text] [Related]
16. Relationships between the severity of cirrhosis and haemodynamic values in patients with cirrhosis.
Meng HC; Lin HC; Tsai YT; Lee FY; Liao DM; Hsia HC; Lin WJ; Chang TT; Lay CS; Wang SS
J Gastroenterol Hepatol; 1994; 9(2):148-53. PubMed ID: 8003648
[TBL] [Abstract][Full Text] [Related]
17. Amino acid dysbalance in liver failure is favourably influenced by recirculating albumin dialysis (MARS).
Loock J; Mitzner SR; Peters E; Schmidt R; Stange J
Liver; 2002; 22 Suppl 2():35-9. PubMed ID: 12220301
[TBL] [Abstract][Full Text] [Related]
18. Molecular adsorbent recirculating system (MARS) application in liver failure: clinical and hemodepurative results in 22 patients.
Stefoni S; Colì L; Bolondi L; Donati G; Ruggeri G; Feliciangeli G; Piscaglia F; Silvagni E; Sirri M; Donati G; Baraldi O; Soverini ML; Cianciolo G; Boni P; Patrono D; Ramazzotti E; Motta R; Roda A; Simoni P; Magliulo M; Borgnino LC; Ricci D; Mezzopane D; Cappuccilli ML
Int J Artif Organs; 2006 Feb; 29(2):207-18. PubMed ID: 16552668
[TBL] [Abstract][Full Text] [Related]
19. Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial.
Bañares R; Nevens F; Larsen FS; Jalan R; Albillos A; Dollinger M; Saliba F; Sauerbruch T; Klammt S; Ockenga J; Pares A; Wendon J; Brünnler T; Kramer L; Mathurin P; de la Mata M; Gasbarrini A; Müllhaupt B; Wilmer A; Laleman W; Eefsen M; Sen S; Zipprich A; Tenorio T; Pavesi M; Schmidt HH; Mitzner S; Williams R; Arroyo V;
Hepatology; 2013 Mar; 57(3):1153-62. PubMed ID: 23213075
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of hepatic venous pressure gradient for in-hospital mortality of patients with severe acute alcoholic hepatitis.
Rincon D; Lo Iacono O; Ripoll C; Gomez-Camarero J; Salcedo M; Catalina MV; Hernando A; Clemente G; Matilla A; Nuñez O; Bañares R
Aliment Pharmacol Ther; 2007 Apr; 25(7):841-8. PubMed ID: 17373923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
